The market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why PMI Stock surged +12.17% Today — RQD Quant Desk Flash
Picard Medical Inc. (PMI) carries a Roarable Rating of C- (Hold) with 61/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
FRED Regime × Technicals: 3% of 52W Range • RSI-14 at 50.2 (NEUTRAL RANGE)
20D Institutional Volume Accumulation (±12.5% realized swing band)
Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment
⚔️ Adversarial Opposing Case: Why the PMI Bull Thesis Could Fail
Even with a 61/100 (C-) score, PMI faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Company executives have done more routine share selling than personal cash buying lately.
Dilution & Margin Drag: Disciplined Float (-0.40% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($7.18) or 200D SMA ($27.52) invalidates the momentum regime and cuts Target Base ($8.22) toward Bear Floor ($6.41).
Why PMI Stock surged +12.17% Today — RQD Quant Desk Flash
Picard Medical Inc. (PMI) surged +12.17% to $8.11, trading at 3% of its 52-week range ($2.65 – $208). Solid steady margins (steady margins), mixed timing at current multiples—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 3% of its 52-week range ($2.65 – $208) with RSI-14 at 50.2 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $8.11 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable C- (Hold) backed by 52% gross margin and $558293 annual free cash flow.
Haley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
Israeli strikes kill eight people in Gaza - medics say Reuters
Russia's FSB says minor detained over park attack threat after US tip-off Reuters
Iran, Qatari mediators hold third day of talks to end US-Iran war Reuters
Qatar surges, bucking Gulf market slide on Iran war concerns Reuters
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
German ministers pledge tough action after rioters damage stores in Frankfurt Reuters
Scheduled RQD Strong Buys & Whale Accumulation Briefing (PMI Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
PMI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on PMI today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for PMI. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PMI)
1. Head-to-Head Health Care Peer Comparison (PMI vs. NSPR, PLRZ, RVP, MODD)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Picard Medical Inc. (PMI) ranks #196 by composite RQD confidence (61/100, grade C-) and #834 by equity capitalization ($19.9M). Within this direct 5-issuer industry benchmark cohort, PMI leads on earnings valuation at N/A trailing P/E, while RVP leads on capital efficiency and profitability with -23.3% ROIC and 0.1% gross margin. PMI currently leads its immediate peer cohort in composite quantitative strength at 61/100 (C-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| PMI
ACTIVE
Picard Medical Inc. | C- | 61/100 | — | — | — | +12.17% | $19.9M | Benchmark Subject |
| NSPR InspireMD Inc. | D- | 38/100 | — | 29.5% | -35.0% | -3.55% | $21.0M | /nspr-vs-pmi → |
| PLRZ Polyrizon Ltd. | D- | 42/100 | — | — | -25.1% | +4.57% | $21.9M | /plrz-vs-pmi → |
| RVP Retractable Technologies Inc. | E | 33/100 | — | 0.1% | -23.3% | -1.15% | $17.3M | /rvp-vs-pmi → |
| MODD Modular Medical Inc. | D- | 36/100 | — | — | -35.0% | -9.95% | $16.3M | /modd-vs-pmi → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2025–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0002030617In its most recent audited fiscal period (FY2025, filed 2025-12-31), Picard Medical Inc. (PMI) reported GAAP revenue of $0 , GAAP net income of $0, operating cash flow of $0, and free cash flow of $0 . On the balance sheet, PMI closed FY2025 with $22.5M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: N/A).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $0 | $0 | — | — | $22.5M | — |
3. PMI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs PMI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Picard Medical Inc. (NYSE: PMI) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 61/100 at a spot price of $8.11 (+12.17% 1D, market cap $19.9M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, PMI ranks #196 in composite RQD confidence.
How does PMI compare to NSPR and PLRZ in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), PMI carries a Roarable C- (61/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, NSPR (InspireMD Inc.) holds a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $21.0M) and PLRZ (Polyrizon Ltd.) posts a D- grade (42/100 RQD, P/E N/A, ROIC -25.1%, cap $21.9M). Among the 5-stock peer group, PMI leads on earnings multiple (N/A) while RVP leads on capital efficiency (-23.3% ROIC).
What are the biggest fundamental strengths and SEC risk factors for PMI?
Per PMI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0002030617), Picard Medical Inc. generated $0 in revenue, $0 in net income, and $0 in free cash flow against $22.5M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is PMI trading relative to its 50-day, 200-day, and 52-week technical levels?
PMI last traded at $8.11 (+12.17% on volume of 71,134 shares), positioning the stock +12.95% above its 50-day simple moving average ($7.18) and -70.53% below its 200-day simple moving average ($27.52). Across its 52-week range of $2.65 to $208.00, PMI sits at the 2.7% percentile with a 14-day RSI of 50.2 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($7.10 to $9.12).
PMI Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is PMI stock moving today?
Why PMI Stock surged +12.17% Today — RQD Quant Desk Flash. Solid steady margins (steady margins), mixed timing at current multiples—hold if owned, no rush to chase.